Viatris Inc. buy melinda
Start price
04.10.17
/
50%
€34.35
Target price
29.12.17
€42.39
Performance (%)
10.68%
End price
29.12.17
€38.02
Summary
This prediction ended on 29.12.17 with a price of €38.02. The BUY prediction by melinda finished with a performance of 10.68%. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Viatris Inc. | 3.369% | 3.369% | 81.191% | 63.074% |
| iShares Core DAX® | 0.271% | 2.504% | 3.327% | 50.436% |
| iShares Nasdaq 100 | 1.884% | 3.490% | 35.658% | 88.226% |
| iShares Nikkei 225® | 3.579% | 8.127% | 56.653% | 65.166% |
| iShares S&P 500 | 0.151% | 1.918% | 24.108% | 64.489% |
Comments by melinda for this prediction
In the thread Viatris Inc. diskutieren
Der Kurs MYL Mylan Inc. zu folgen hat einen neuen Höchststand von 26 Wochen erreicht
$$
Die Mylan Inc MYL Preis hat einen neuen Höchststand von 26 Wochen erreicht
NV Mylan (MYL) gewinnt FDA - Zulassung für die erste Generation Copaxone; Die Aktie stieg um 17%
(Vom Mitglied beendet)